150 related articles for article (PubMed ID: 35969832)
21. Incidence Trends and Burden of Human Papillomavirus-Associated Cancers Among Women in the United States, 2001-2017.
Deshmukh AA; Suk R; Shiels MS; Damgacioglu H; Lin YY; Stier EA; Nyitray AG; Chiao EY; Nemutlu GS; Chhatwal J; Schmeler K; Sigel K; Sonawane K
J Natl Cancer Inst; 2021 Jun; 113(6):792-796. PubMed ID: 32833021
[TBL] [Abstract][Full Text] [Related]
22. Quadrivalent Human Papillomavirus Vaccine: Recommendations of the Advisory Committee on Immunization Practices (ACIP).
Markowitz LE; Dunne EF; Saraiya M; Lawson HW; Chesson H; Unger ER; ;
MMWR Recomm Rep; 2007 Mar; 56(RR-2):1-24. PubMed ID: 17380109
[TBL] [Abstract][Full Text] [Related]
23. HPV-related cancers after solid organ transplantation in the United States.
Madeleine MM; Finch JL; Lynch CF; Goodman MT; Engels EA
Am J Transplant; 2013 Dec; 13(12):3202-9. PubMed ID: 24119294
[TBL] [Abstract][Full Text] [Related]
24. Effect of human papillomavirus vaccines on vulvar, vaginal, and anal intraepithelial lesions and vulvar cancer.
Hampl M; Sarajuuri H; Wentzensen N; Bender HG; Kueppers V
Obstet Gynecol; 2006 Dec; 108(6):1361-8. PubMed ID: 17138767
[TBL] [Abstract][Full Text] [Related]
25. Epidemiology of human papillomavirus infection and cervical cancer and future perspectives in Hong Kong, Singapore and Taiwan.
Tay SK; Ngan HY; Chu TY; Cheung AN; Tay EH
Vaccine; 2008 Aug; 26 Suppl 12():M60-70. PubMed ID: 18945415
[TBL] [Abstract][Full Text] [Related]
26. A systematic review of the prevalence and attribution of human papillomavirus types among cervical, vaginal, and vulvar precancers and cancers in the United States.
Insinga RP; Liaw KL; Johnson LG; Madeleine MM
Cancer Epidemiol Biomarkers Prev; 2008 Jul; 17(7):1611-22. PubMed ID: 18628412
[TBL] [Abstract][Full Text] [Related]
27. [AN HPV-ASSOCIATED DISEASES AND CERVICAL CANCER AND PROPHYLACTIC HUMAN PAPILLOMAVIRUS (HPV) VACCINES].
Malinova M
Akush Ginekol (Sofiia); 2015; 54 Suppl 1():25-31. PubMed ID: 26137767
[TBL] [Abstract][Full Text] [Related]
28. Human papillomavirus infections and vulvar disease development.
Garland SM; Insinga RP; Sings HL; Haupt RM; Joura EA
Cancer Epidemiol Biomarkers Prev; 2009 Jun; 18(6):1777-84. PubMed ID: 19505910
[TBL] [Abstract][Full Text] [Related]
29. Indications and efficacy of the human papillomavirus vaccine.
Hakim AA; Lin PS; Wilczynski S; Nguyen K; Lynes B; Wakabayashi MT
Curr Treat Options Oncol; 2007 Dec; 8(6):393-401. PubMed ID: 18172770
[TBL] [Abstract][Full Text] [Related]
30. Human papillomavirus-associated carcinomas in Hawaii and the mainland U.S.
Frisch M; Goodman MT
Cancer; 2000 Mar; 88(6):1464-9. PubMed ID: 10717631
[TBL] [Abstract][Full Text] [Related]
31. Cervical Precancers and Cancers Attributed to HPV Types by Race and Ethnicity: Implications for Vaccination, Screening, and Management.
Mix J; Saraiya M; Hallowell BD; Befano B; Cheung LC; Unger ER; Gargano JW; Markowitz LE; Castle PE; Raine-Bennett T; Walker J; Zuna R; Schiffman M; Wentzensen N; Gage JC
J Natl Cancer Inst; 2022 Jun; 114(6):845-853. PubMed ID: 35176161
[TBL] [Abstract][Full Text] [Related]
32. The Relationships Between Social Media and Human Papillomavirus Awareness and Knowledge: Cross-sectional Study.
Jo S; Pituch KA; Howe N
JMIR Public Health Surveill; 2022 Sep; 8(9):e37274. PubMed ID: 36125858
[TBL] [Abstract][Full Text] [Related]
33. Human Papillomavirus Genotypes From Vaginal and Vulvar Intraepithelial Neoplasia in Females 15-26 Years of Age.
Garland SM; Joura EA; Ault KA; Bosch FX; Brown DR; Castellsagué X; Ferenczy A; Ferris DG; Giuliano AR; Hernandez-Avila M; Huh WK; Iversen OE; Kjaer SK; Kurman RJ; Luna J; Monsonego J; Muñoz N; Paavonen J; Pitisuttihum P; Ronnett BM; Steben M; Stoler MH; Wheeler CM; Wiley DJ; Perez G; Saah AJ; Luxembourg A; Li S; DiNubile MJ; Wagner M; Velicer C
Obstet Gynecol; 2018 Aug; 132(2):261-270. PubMed ID: 29995724
[TBL] [Abstract][Full Text] [Related]
34. Public health impact and cost effectiveness of routine and catch-up vaccination of girls and women with a nine-valent HPV vaccine in Japan: a model-based study.
Cody P; Tobe K; Abe M; Elbasha EH
BMC Infect Dis; 2021 Jan; 21(1):11. PubMed ID: 33407188
[TBL] [Abstract][Full Text] [Related]
35. Prevention of Human Papillomavirus Infection. Beyond Cervical Cancer: A Brief Review.
Medeiros R; Vaz S; Rebelo T; Figueiredo-Dias M
Acta Med Port; 2020 Mar; 33(3):198-201. PubMed ID: 32130098
[TBL] [Abstract][Full Text] [Related]
36. HPV-Related Cancers: A Growing Threat to U.S. Military Health and Readiness.
Seay J; Matsuno R; Buechel J; Tannenbaum K; Wells N
Mil Med; 2022 May; 187(5-6):149-154. PubMed ID: 34697641
[TBL] [Abstract][Full Text] [Related]
37. In situ and invasive squamous cell carcinoma of the vulva in Denmark 1978-2007-a nationwide population-based study.
Baandrup L; Varbo A; Munk C; Johansen C; Frisch M; Kjaer SK
Gynecol Oncol; 2011 Jul; 122(1):45-9. PubMed ID: 21474166
[TBL] [Abstract][Full Text] [Related]
38. [Epidemiology of vulvar intra-epithelial neoplasias].
Akerman G; Dussour C; Haddad B; Paniel BJ; Rouzier R
Gynecol Obstet Fertil; 2007 Dec; 35(12):1251-6. PubMed ID: 18054264
[TBL] [Abstract][Full Text] [Related]
39. Quadrivalent human papillomavirus vaccine.
Barr E; Tamms G
Clin Infect Dis; 2007 Sep; 45(5):609-7. PubMed ID: 17682997
[TBL] [Abstract][Full Text] [Related]
40. Five-year relative survival for human papillomavirus-associated cancer sites.
Razzaghi H; Saraiya M; Thompson TD; Henley SJ; Viens L; Wilson R
Cancer; 2018 Jan; 124(1):203-211. PubMed ID: 29105738
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
